Zhong Lecture
ROCKY VISTA UNIVERSITY
Instructor Information
Dr. Qing Zhong, MD, PhD
Email: gzhong@rvu.edu
Location: Ivins, C224
Course Objectives
Describe physiological responses in cardiovascular (CV) and respiratory systems when sympathetic nervous system activates.
Correlate responses to specific tissues and receptor subtypes.
Describe the baroreceptor reflex in detail.
Include neurotransmitters, receptors, and cardiac and vascular responses.
Analyze cardiovascular responses to autonomic drugs.
Differentiate direct effects on autonomic receptors from indirect reflex mechanisms.
Differentiate direct and indirect adrenergic agonists.
Distinguish between selective and nonselective adrenergic agonists and antagonists for α1, α2, β1, and β2 receptors.
List mechanisms, applications, and side effects of cardiovascular drugs:
Nitroglycerin, Amlodipine, Verapamil, Digoxin.
Apply knowledge to clinical scenarios and case studies.
Drugs Overview
Sympathomimetics (Adrenergic Agonists)
List of Drugs:
Phenylephrine
Dobutamine
Albuterol
Isoproterenol
Norepinephrine
Epinephrine
Dopamine
Amphetamine
Other Cardiovascular System Drugs
Drugs Affecting cGMP:
Nitroglycerin
L-calcium channel blockers:
Amlodipine
Verapamil
Digoxin
Sympatholytics (Adrenergic Antagonists/Blockers)
List of Drugs:
Propranolol
Metoprolol
Carvedilol
Phentolamine (α1, α2)
Prazosin (α1)
Special Cases
Clonidine (α2 agonist): classified under sympatholytics because it decreases blood pressure.
Note: Red font drugs will be covered in assessments; blue font indicates important concepts.
Adrenergic Agonists
Direct vs. Indirect Agonists
Direct adrenergic agonists:
Activate adrenergic receptors directly.
Examples: Alpha receptor agonists, Beta receptor agonists.
Indirect adrenergic agonists:
Increase norepinephrine levels in the synaptic cleft without directly activating adrenergic receptors.
Examples: Amphetamine, Cocaine, Tyramine, and Ephedrine.
Also termed sympathomimetics as they emulate endogenous sympathetic nervous system actions.
Baroreceptor Reflex
Function and Mechanism
Baroreceptors: Sense vessel stretch; increased stretch causes increased depolarization.
Increased Blood Pressure (BP):
Baroreceptors increase afferent nerve activity.
CNS medulla reduces sympathetic output and enhances parasympathetic output.
Effects:
Decreased sympathetic activity.
Reduced norepinephrine release -> Less β1 activity.
Increased M2 activity -> Heart rate reduced.
Alterations in renal renin release.
Decreased BP: Opposite responses to increased BP occur. Heart rate increases and renin release is augmented.
Adrenergic Receptors and Drugs
Alpha and Beta Receptors
α1: Sphincter contraction, mydriasis.
α2: Inhibit norepinephrine release (Centrally and peripherally).
β1: Increases heart rate and contraction force.
β2: Bronchodilation and vasodilation.
Catecholamines
Norepinephrine:
Structure: HO-(side chain)-NH2
Effects: Increases BP, heart rate.
Epinephrine: Similar structure to norepinephrine with additional hydroxyl groups.
Acts on both alpha and beta receptors.
Isoproterenol: Selective beta agonist.
Primarily acts on β1 and β2 receptors.
Dopamine: A precursor; effects depend on dose.
Clinical Applications
Phenylephrine
Mechanism: Selective α1 agonist leading to increased BP.
Uses: Nasal decongestant, pupil dilation.
Side Effects: Delayed reflex bradycardia.
Dobutamine
Mechanism: Selective β1 agonist used to improve heart function.
Used For: Acute heart failure management.
Selective β2 Agonists
Albuterol:
Primary use in asthma treatment.
Side Effects: Tremor, tachycardia.
Terbutaline: Used for premature labor.
Norepinephrine and Epinephrine Dosing
Norepinephrine
Actions: Increases TPR, BP due to α1 activation.
Cardiovascular effects: Reflex bradycardia possible due to BP increase.
Epinephrine
Low Dose: β > α receptor affinity.
Decreases TPR, slight decreases in diastolic pressure.
Medium Dose: α = β, SBP increases, DBP decreases, minimal change in mean BP.
High Dose: α > β, leads to significant increases in systemic BP due to vasoconstriction.
Dopamine
Dose-dependent actions:
Low dose (1-3 μg/kg/min): stimulate D1 receptors, enhancing blood flow.
Moderate dose (3-7.5 μg/kg/min): stimulate β1 receptors, increasing cardiac output.
High dose (>10 μg/kg/min): stimulates α1 receptors, inducing significant vascular resistance.
Use: Cardiac or septic shock.
Drugs Affecting cGMP
Nitroglycerin
Mechanism: Donates nitric oxide, increasing cGMP levels leading to vasodilation.
Uses: Primarily in treating angina.
Side Effects: Reflex tachycardia.
L-type Calcium Channel Blockers
Dihydropyridine
Example: Amlodipine
Mechanism: Causes vasodilation in arterioles.
Uses: Hypertension treatment.
Side Effects: Ankle edema, constipation.
Non-dihydropyridine
Example: Verapamil
Mechanism: Decreases heart contractility and rate.
Uses: Treats tachyarrhythmias.
Side Effects: Risk of heart failure, AV block.
Digoxin
Mechanisms of Action
Inotropic effect:
Inhibits Na+/K+-ATPase -> Increased cytosolic calcium leading to enhanced contractility.
Para-sympathomimetic effect:
Reduces A-V conduction due to enhanced parasympathetic tone triggered by elevated calcium.
Clinical Use
Treats atrial fibrillation and heart failure.
Side Effects: GI upset, arrhythmia, CNS disturbances (e.g., visual changes).
Risk: Digoxin toxicity, especially in patients with renal dysfunction.
Summary of Important Concepts
Blood Pressure Equation:
BP = CO imes TPR = SV imes HR imes TPRKey Terms:
CO = Cardiac Output
TPR = Total Peripheral Resistance
SV = Stroke Volume
Baroreflex Mechanism: Important in modulating heart rate based on BP changes.
Practice Questions
Q1: Activation of which receptors by norepinephrine at therapeutic doses?
A. M3
B. β1
C. β1, β2
D. α1, α2, β1
E. α1, α2, β1, β2
Q2: Which drug is a selective beta-2 agonist?
Q3: Identify the selective beta-1 blocker.
Q4: Which drug reduces heart contraction?
References
Katzung BG, Basic & Clinical Pharmacology, 16th Edition, 2023. McGraw-Hill Education.
David C, Harris SR. Kaplan USMLE Pharmacology lecture note.
UWorld Step 1 Q bank.